Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Alphavirus vectors for respiratory pathogen vaccines

Alphavirus vectors for respiratory pathogen vaccines

US Patent 9730997 · Granted Aug 15, 2017

Estimated economic value: $13,050,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric alphavirus replicon particles2016
Chimeric alphavirus replicon particles2016
Alphavirus replicon packaging constructs2015
Alphavirus replicon packaging constructs2015
Compositions and methods for generating an immune response utilizing alphavirus-2014
Expression of HIV polypeptides and production of virus-like particles2012
Chimeric alphavirus replicon particles2012
Chimeric alphavirus replicon particles2012
Eukaryotic layered vector initiation systems2011
Method for producing yeast expressed HPV types 6 and 16 capsid proteins2011
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromo2010
Compositions and methods for generating an immune response utilizing alphavirus-2010